- Home
- LINC vs MGTX Comparison
LINC vs MGTX Comparison
Compare LINC & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINC
- MGTX
- Stock Information
- Founded
- LINC 1946
- MGTX 2015
- Country
- LINC United States
- MGTX United States
- Employees
- LINC 2475
- MGTX 386
- Industry
- LINC Other Consumer Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LINC Real Estate
- MGTX Health Care
- Exchange
- LINC Nasdaq
- MGTX Nasdaq
- Market Cap
- LINC 732.0M
- MGTX 701.5M
- IPO Year
- LINC 2005
- MGTX N/A
- Fundamental
- Price
- LINC $23.26
- MGTX $8.74
- Analyst Decision
- LINC Strong Buy
- MGTX Strong Buy
- Analyst Count
- LINC 4
- MGTX 3
- Target Price
- LINC $24.50
- MGTX $25.67
- AVG Volume (30 Days)
- LINC 213.1K
- MGTX 441.5K
- Earning Date
- LINC 11-10-2025
- MGTX 11-12-2025
- Dividend Yield
- LINC N/A
- MGTX N/A
- EPS Growth
- LINC 79.82
- MGTX N/A
- EPS
- LINC 0.46
- MGTX N/A
- Revenue
- LINC $467,763,000.00
- MGTX $37,917,000.00
- Revenue This Year
- LINC $14.51
- MGTX $144.79
- Revenue Next Year
- LINC $8.40
- MGTX $168.58
- P/E Ratio
- LINC $50.82
- MGTX N/A
- Revenue Growth
- LINC 14.53
- MGTX 366.84
- 52 Week Low
- LINC $12.35
- MGTX $4.55
- 52 Week High
- LINC $25.76
- MGTX $9.44
- Technical
- Relative Strength Index (RSI)
- LINC 62.22
- MGTX 57.84
- Support Level
- LINC $21.36
- MGTX $8.42
- Resistance Level
- LINC $23.55
- MGTX $9.44
- Average True Range (ATR)
- LINC 0.69
- MGTX 0.62
- MACD
- LINC 0.09
- MGTX 0.06
- Stochastic Oscillator
- LINC 87.20
- MGTX 65.99
About LINC Lincoln Educational Services Corporation
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.